# Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

> **NCT05194878** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 840 (estimated)

## Conditions studied

- Colon Cancer Stage II
- Colon Cancer Stage III

## Interventions

- **DRUG:** neoadjuvant chemotherapyI
- **PROCEDURE:** Colectomy
- **DRUG:** adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT05194878
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2024-12
- **Final completion:** 2026-12
- **Target enrollment:** 840 (ESTIMATED)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05194878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05194878, "Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05194878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*